Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00719589 · ClinicalTrials.gov registry record
Outcomes of Pudendal InterStim
A clinical trial, sponsored by Corewell Health East.
- Completed
- Registry status
- 84
- Enrollment target
NCT00719589: Completed study, sponsored by Corewell Health East.
NCT00719589 is a clinical trial that has completed, run by Corewell Health East. The registered enrollment target is 84 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00719589 has completed, sponsored by Corewell Health East.
- COMPLETED
- Registry status
- 84 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how many patients who have failed treatment with a sacral lead can achieve good results with a pudendal, patients satisfaction with the results of each lead, complication rates after pudendal lead placement, and how many patients have required reprogramming of their device with EMG testing( a more costly procedure).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2008-07 |
| Est. Completion | 2010-01 |
What the finished NCT00719589 record still lists
NCT00719589 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 84 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00719589 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00719589 about?
NCT00719589 is a clinical study titled "Outcomes of Pudendal InterStim". The purpose of this study is to determine how many patients who have failed treatment with a sacral lead can achieve good results with a pudendal, patients satisfaction with the results of each lead, complication rates after pudendal lead placement, and how many patients have required reprogramming ...
What is the current status of trial NCT00719589?
This trial is currently completed. The enrollment target is 84 participants. The study started on 2008-07. Estimated completion is 2010-01.
Who is sponsoring clinical trial NCT00719589?
This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia